| human | Q5 |
| P856 | official website | https://scholars.lib.ntu.edu.tw/cris/rp/rp06847/ |
| P496 | ORCID iD | 0000-0001-6383-3470 |
| P1153 | Scopus author ID | 7203056934 |
| P108 | employer | National Taiwan University Hospital | Q1418766 |
| P106 | occupation | researcher | Q1650915 |
| Q121763486 | A 3D culture system for evaluating the combined effects of cisplatin and anti-fibrotic drugs on the growth and invasion of lung cancer cells co-cultured with fibroblasts |
| Q36214551 | Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib. |
| Q39559009 | Analysis of the paracrine loop between cancer cells and fibroblasts using a microfluidic chip |
| Q52687052 | Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non-Small-cell Lung Cancer Patients. |
| Q38773430 | Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis. |
| Q52639666 | Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum. |
| Q54261758 | Discordant HER2 Exon 20 Mutation Status Determines a Differential Sensitivity to Afatinib. |
| Q84075816 | Dynamics of cancer cell filopodia characterized by super-resolution bright-field optical microscopy |
| Q35863205 | EGFR mutation and lobar location of lung adenocarcinoma |
| Q37384835 | Emphysematous gastritis: a deadly infectious disease. |
| Q84621510 | Endobronchial ultrasound-guided transbronchial biopsy of peripheral pulmonary lesions: how many specimens are necessary? |
| Q47982258 | Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery. |
| Q86216079 | GM2-activator protein: a new biomarker for lung cancer |
| Q27851784 | Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinum. |
| Q24815017 | Global expression profiling of theophylline response genes in macrophages: evidence of airway anti-inflammatory regulation |
| Q55058467 | Heparin co-factor II enhances cell motility and promotes metastasis in non-small cell lung cancer. |
| Q35196603 | Identification of five driver gene mutations in patients with treatment-naïve lung adenocarcinoma in Taiwan |
| Q39205255 | Interaction between lung cancer cell and myofibroblast influenced by cyclic tensile strain. |
| Q39871624 | Label-free quantification of asymmetric cancer-cell filopodium activities in a multi-gradient chip. |
| Q37685942 | Modulating chemotaxis of lung cancer cells by using electric fields in a microfluidic device |
| Q47962291 | Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy |
| Q85842483 | Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer |
| Q47777525 | Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study |
| Q74597363 | Pneumothorax in the ICU: patient outcomes and prognostic factors |
| Q40329884 | Predictive factors for EGFR-tyrosine kinase inhibitor retreatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter retrospective SEQUENCE study |
| Q33706859 | Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaïve patients with EGFR-mutant lung adenocarcinoma. |
| Q35994784 | Prospective Evaluation of Procalcitonin, Soluble Triggering Receptor Expressed on Myeloid Cells-1 and C-Reactive Protein in Febrile Patients with Autoimmune Diseases |
| Q47660376 | Psychological distress and coping strategies among women with incurable lung cancer: a qualitative study |
| Q48084661 | Quality of life and related factors in patients with newly diagnosed advanced lung cancer: a longitudinal study |
| Q36372611 | Real-World Data on Prognostic Factors for Overall Survival in EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Gefitinib |
| Q34474093 | Risk factors of pneumothorax after endobronchial ultrasound-guided transbronchial biopsy for peripheral lung lesions. |
| Q87389555 | Survival of lung adenocarcinoma patients with malignant pleural effusion |
| Q80241015 | TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer |
| Q39426202 | The migration speed of cancer cells influenced by macrophages and myofibroblasts co-cultured in a microfluidic chip |
| Q38908719 | The unmet supportive care needs-what advanced lung cancer patients' caregivers need and related factors. |
| Q47765155 | The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms. |
| Q73281988 | US-guided transthoracic cutting biopsy for peripheral thoracic lesions less than 3 cm in diameter |
| Q81079464 | Value of imprint cytology for ultrasound-guided transthoracic core biopsy |
Search more.